Anagnostics’ Companion Diagnostics Tests
28 Apr 2014
In the field of oncology in particular, targeted therapies are used because at molecular levels tumors differ from one another. This calls for a corresponding therapy in each case. Anagnostics’ tests used in mutation analysis provide sensitive results which are specific for each individual mutation of clinical relevance. Watch this video to see how Anagnostics' companion diagnostics tests are processed.
About the company
Anagnostics Bioanalysis
We specialize in developing systems and tests for research and clinical in-vitro diagnostic procedures. Our aim is to provide solutions for unmet needs, especially in the fields of multiplexed protein and nucleic acid analysis.
Since 2005 our ambitious team around molecular geneticist Dr. Bernhard Ronacher develops a new multiplex assay and diagnostics technology. A cylindrical microarray, the patented hybcell, is the core of our technology.
Our vision is to establish hybcell technology in pharmaceutical research and clinical diagnostics.
Some of the benefits of our multiplex technology are the following:
- Precise, quick and cost-effective results
- Highly flexible assay design
- The possibility to measure kinetics
- Fully automated assay procedure
- Unprecedented ease of use for microarray assays
